Trials / Unknown
UnknownNCT01280214
Local Triamcinolone Injection in Active Thyroid Orbitopathy
Peribulbar and Subconjunctival Kenalog Injection for Thyroid Orbitopathy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparing the effectiveness of subconjunctival and peribulbar Triamcinolone injection to systemic Steroid therapy for patients with active thyroid orbitopathy.
Detailed description
Local Steroid treatment may help in active thyroid orbitopathy. till today, systemic Steroids are the treatment for active thyroid orbitopathy which is associated with systemic adverse effects. In this study the investigators want to compare the effectiveness of local Triamcinolone therapy for active thyroid orbitopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone | Subconjunctival and peribulbar, 40 mg/ml, 3 monthly injection |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2011-01-20
- Last updated
- 2011-01-20
Source: ClinicalTrials.gov record NCT01280214. Inclusion in this directory is not an endorsement.